Biovail (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Biovail" in English language version.

refsWebsite

Global rank English rank

4web.archive.org

1^st place

2nytimes.com

7^th place

2cjr.org

4,313^th place

2,441^st place

1gov.on.ca

3,596^th place

2,126^th place

1reuters.com

49^th place

47^th place

1forbes.com

54^th place

48^th place

1casetext.com

4,010^th place

2,209^th place

1cbsnews.com

108^th place

80^th place

1sec.gov

572^nd place

436^th place

1gradientanalytics.com

low place

1prnewswire.com

406^th place

258^th place

1ottawacitizen.com

3,584^th place

1,998^th place

casetext.com

"Fort Worth Employers' Retirement Fund v. Biovail Corp., 615 F. Supp. 2d 218 | Casetext Search + Citator". casetext.com. Retrieved 2024-10-02.

cbsnews.com

"Betting on a Fall", Lesley Stahl, 60 Minutes story on Biovail lawsuit Archived May 27, 2008, at the Wayback Machine

cjr.org

forbes.com

"Biovail faces lawsuit over depression drug". Associated Press. 2008-09-10. Archived from the original on October 12, 2008.

gov.on.ca

osc.gov.on.ca

paragraph 44 of OSC Settlement https://www.osc.gov.on.ca/documents/en/Proceedings-SET/set_20090210_crombieb.pdf

gradientanalytics.com

Gradient Analytics' Early Research Identified Same Issues as Charges in SEC Complaint Against Biovail. SEC Credits Analysts Who Questioned Biovail, but Retaliation Against Independent Researchers Through Lawsuits Continues Archived 2008-07-08 at the Wayback Machine, Gradient Analytics press release, March 25, 2008 (PDF)

nytimes.com

U.S. and Canada Accuse Drug Maker of Fraud, Ian Austin, The New York Times, March 25, 2008
Nocera, Joe (April 2006). "No Free Title: "To continue reading the page you requested, you must be a subscriber to TimesSelect"". The New York Times.

ottawacitizen.com

"Senators owner Melnyk banned for five years from boardrooms of public companies The Financial Post by Barbara Shector, May 5, 2011". Retrieved 2011-05-05.

prnewswire.com

"Valeant Pharmaceuticals and Gradient Analytics Settle Lawsuit" (Press release).

reuters.com

"Drugmaker Biovail to buy Valeant in $3.3 billion deal". Reuters. June 21, 2010. Archived from the original on October 6, 2015. Retrieved July 3, 2017.

sec.gov

SEC Charges Biovail Corporation and Senior Executives With Accounting Fraud, U.S. Securities and Exchange Commission press release, March 24, 2008

web.archive.org

"Drugmaker Biovail to buy Valeant in $3.3 billion deal". Reuters. June 21, 2010. Archived from the original on October 6, 2015. Retrieved July 3, 2017.
"Biovail faces lawsuit over depression drug". Associated Press. 2008-09-10. Archived from the original on October 12, 2008.
"Betting on a Fall", Lesley Stahl, 60 Minutes story on Biovail lawsuit Archived May 27, 2008, at the Wayback Machine
Gradient Analytics' Early Research Identified Same Issues as Charges in SEC Complaint Against Biovail. SEC Credits Analysts Who Questioned Biovail, but Retaliation Against Independent Researchers Through Lawsuits Continues Archived 2008-07-08 at the Wayback Machine, Gradient Analytics press release, March 25, 2008 (PDF)